SEC Form 4 · accession 0001209191-15-040001
SKYSTAR BIO-PHARMACEUTICAL CO · SKBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Gregory
10% Owner
Period of report
May 6, 2015
Accepted (ET)
May 7, 2015 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001076939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 6, 2015 | P | 50,000 | $3.47 | A | 507,750 | I | By SJ Strategic Investments, LLC |
| Common Stock | holding | — | — | — | 193,500 | D | ||
| Common Stock | holding | — | — | — | 466,000 | I | By Kingsway Charities, In. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.36 to $3.57 inclusive. The reporting person undertakes to provide the Issuer, any stockholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.